AN APPROACH FOR DESIGN AND CHARACTERIZATION OF NIOSOMES FOR CHLORPHENIRAMINE MALEATE
Full text
Figure
Related documents
Figure 8.31: Cumulative % drug release profile of formulation F7 – F9 Dissolution Profile of Mouth Dissolving Loratadine Tablets (F1 - F9). Figure 8.32: Cumulative % drug
In-vitro release study was carried out and revealed that cumulative % drug release in chewing gum formulations were decreases with increases concentration of gum base. From
Table 1: Tablet composition of different formulations of Bosentan matrix tablets containing controlled release polymers.. Fig 1: Cumulative Percent of Dissolution Date
Niosomal formulations using various surfactants (Span 40, Span 60 and Span 80) were prepared by thin film hydration technique. The best formulation was chosen among
The invitro drug release decreased with increase in the polymer.Analysis of drug release mechanism showed that the drug release from the formulations followed
Formulations were evaluated for weight variation, hardness, friability, drug content, swelling studies, surface pH, bioadhesion strength, invitro drug release,
• The niosomal formulations were evaluated for drug content, entrapment efficiency, in vitro release studies, and kinetic drug release. • The percentage drug content of
The % cumulative drug release (CDR) of all formulations of oral fast dissolving film of domperidone is given in Table 8. Figure 3: % Cumulative drug release of reference formulation